Aurinia Pharmaceuticals Inc. Shares Outstanding (Cover Page)
Aurinia Pharmaceuticals Inc. (AUPH) had Shares Outstanding (Cover Page) of 133.05 million shares as of 2026-08-05, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-05: Entity Common Stock, Shares Outstanding 133.05M shares.
- 2026-05-06: Entity Common Stock, Shares Outstanding 128.60M shares.
- 2026-02-25: Entity Common Stock, Shares Outstanding 132.97M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 131.84M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-05 | 133.05M shares 10-Q · filed 2026-08-06 |
| 2026-05-06 | 128.60M shares 10-Q · filed 2026-05-07 |
| 2026-02-25 | 132.97M shares 10-K · filed 2026-02-26 |
| 2025-11-03 | 131.84M shares 10-Q · filed 2025-11-04 |
| 2025-07-29 | 131.63M shares 10-Q · filed 2025-07-31 |
| 2025-05-08 | 135.10M shares 10-Q · filed 2025-05-12 |
| 2025-02-25 | 137.34M shares 10-K · filed 2025-02-27 |
| 2024-11-06 | 143.18M shares 10-Q · filed 2024-11-07 |
| 2024-07-31 | 142.99M shares 10-Q · filed 2024-08-01 |
| 2024-05-01 | 143.02M shares 10-Q · filed 2024-05-02 |
| 2024-04-26 | 143.02M shares 10-K/A · filed 2024-04-29 |
| 2024-02-14 | 144.62M shares 10-K · filed 2024-02-15 |
| 2023-11-01 | 143.61M shares 10-Q · filed 2023-11-02 |
| 2023-08-02 | 143.42M shares 10-Q · filed 2023-08-03 |
| 2023-05-03 | 143.03M shares 10-Q · filed 2023-05-04 |
| 2023-02-27 | 142.58M shares 10-K · filed 2023-02-28 |
| 2022-11-02 | 142.11M shares 10-Q · filed 2022-11-03 |
| 2022-08-03 | 141.89M shares 10-Q · filed 2022-08-04 |
| 2022-05-09 | 141.74M shares 10-Q · filed 2022-05-10 |
| 2022-02-25 | 141.65M shares 10-K · filed 2022-02-28 |
| 2021-11-02 | 129.67M shares 10-Q · filed 2021-11-03 |
| 2021-08-04 | 128.40M shares 10-Q · filed 2021-08-05 |
| 2021-05-06 | 128.16M shares 10-Q · filed 2021-05-06 |
| 2021-04-19 | 128.12M shares 10-K/A · filed 2021-04-30 |
| 2021-02-24 | 127.45M shares 10-K · filed 2021-02-24 |
| 2019-12-31 | 111.80M shares 40-F · filed 2020-03-05 |
| 2018-12-31 | 85.50M shares 40-F · filed 2019-03-19 |
| 2017-12-31 | 84.05M shares 40-F · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B |